Assoc Director Patient Safety Scientist Full-time

Assoc Director Patient Safety Scientist

Location: Warsaw

Hybrid Model: 3 days per week from office

The Pharmacovigilance (PV) Scientist role works collaboratively with the Global Safety Physician (GSP) and (Senior/Principal) PV Scientist with the review of safety data and related documents for potential safety issues. He/she has the ability to provide authoring and PV input to safety documents and regulatory reports. PV Scientist also has the ability to lead meetings and present safety data and analyses.

Main Responsibilities:

• Leads and/or conducts proactive pharmacovigilance and risk management planning for designated products, including preparation of safety aspects of Global Risk Management Plans, in partnership with the GSP and others as appropriate.
• Represents PS on cross-functional project teams for developmental compounds and/or marketed products.
• Has the ability to present safety information at external meetings.
• Has the ability to perform duties as a Safety Strategy and Management Team (SSaMT) leader for smaller or less complex projects.
• Presents issues to Safety Information Review Committee (SIRC) and has the capacity to take the lead role in data evaluation and discussion of the results with the SIRC Chair, GSP and other key stakeholders.
• Produces accurate and fit for purpose evaluation documents with clear conclusions in response to internal or regulatory authority requests for safety data.
• Collaborates with GSP and Clinical representatives and authors the Reference Safety Information (RSI) for assigned development products; coordinates meetings and tracks timelines to ensure completion.
• Proactively evaluates the clinical implications of safety data from pre-clinical studies, clinical studies, literature and other information sources to establish the safety profile of drugs and manage the risk to patients.
• Authors/provides strategic input or oversight for periodic regulatory documents (PBRERs, PSURs, DSURs) according to the agreed process and timelines.
• Authors/provides strategic input to regulatory submissions for new products, formulations or indications (NDA/BLA, MAA), in partnership with the GSP and other functional experts.
• Contributes to the PS component of contracts/agreements with third parties to ensure quality and integrity of agreement.
• Trains junior members of the team in PS tools and systems.

Requirements – Education and Experience:

• A life sciences/pharmacy/nursing degree and demonstrated Patient Safety and/or Clinical/Drug Development experience.
• Intermediate knowledge of PV regulations
• Fluent in written and verbal English
• MD, MSc/PhD in scientific discipline, preferred
• Basic understanding of epidemiology data, preferred

What We Offer:

Welcome to Warsaw Site, one of over 400 sites here at AstraZeneca, providing a collaborative environment where everyone feels comfortable and able to be themselves is at the core of AstraZeneca's priorities, it's important to us that you bring your full self to work every day.

To help you maintain your best self, here's a sneak peek into some of the things this site provides for you:

• The best team to support you,
• Multisport card,
• Pension plan,
• Life insurance,
• After-work events,
• Private medical care
• Lunch card,
• Bright and spacious environment,
• Sustainable office working environment.

Please note that we are working in a hybrid model of 3 days per week from the office in Warsaw

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.